here is a list of biotech companies with emerging Head and Neck cancer Drugs Under Different Phases of Clinical Development
• CLR 131: Cellectar Biosciences, Inc.
• MEM-288: Memgen, Inc.
• IK 175: Ikena Oncology
• Tigilanol Tiglate: QBiotics Group Limited
• BNT 113: BioNTech
• Niraparib: GlaxoSmithKline
• Atezolizumab: Hoffmann-La Roche
• Xevinapant: Merck
extract from an article https://www.openpr.com/news/2891022/head-and-neck-cancer-pipeline-drugs-and-companies-insight-report
- Forums
- ASX - By Stock
- Qbiotics
here is a list of biotech companies with emerging Head and Neck...
Featured News
Featured News
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online